Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFidelity E.m.ld Regulatory News (FEML)

Share Price Information for Fidelity E.m.ld (FEML)

Share Price is delayed by 15 minutes
Get Live Data
1,400.00    -12.00 (-0.85%)
Bid:
1,398.00
Ask:
1,404.00
Spread: 6.00 (0.429%)
Market Cap: £565.34m
FEML Live PriceLast checked at - London Stock Exchange

Intraday Fidelity E.m.ld Share Chart

Initiation from QuotedData

5 Feb 2026 13:15

RNS Number : 9306R
Fidelity Emerging Markets Limited
05 February 2026
 

Fidelity Emerging Markets - Initiation from QuotedData

5 February 2026

The long and short of emerging markets

Fidelity Emerging Markets Limited (FEML) gives investors access to a wide range of emerging market shares. The managers have a flexible approach, investing in companies of all sizes and spreading investments across different countries and sectors. A key feature is the use of both long and short positions, allowing the fund to benefit from opportunities in both strong and weaker companies.

Performance has been strong over the past year, supported by favourable conditions for emerging markets. The discount to net asset value (NAV) has also narrowed, and there is potential for it to reduce further if investor sentiment improves.

Full Research:

https://quoteddata.com/research/fidelity-emerging-markets-the-long-and-short-of-emerging-markets-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note Fidelity Emerging Markets Limited, and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRASSSFDIEMSEFE
Date   Source Headline
1st Dec 20252:21 pmPRNTotal Voting Rights
1st Dec 20251:46 pmPRNResult of AGM
1st Dec 20257:59 amRNSNet Asset Value(s)
28th Nov 20255:02 pmPRNTransaction in Own Shares
28th Nov 20258:24 amRNSNet Asset Value(s)
27th Nov 20257:52 amRNSNet Asset Value(s)
26th Nov 20255:11 pmPRNTransaction in Own Shares
26th Nov 20257:55 amRNSNet Asset Value(s)
25th Nov 20255:35 pmPRNTransaction in Own Shares
25th Nov 20253:20 pmPRNMonthly Factsheet
25th Nov 20257:59 amRNSNet Asset Value(s)
24th Nov 20258:01 amRNSNet Asset Value(s)
21st Nov 20255:28 pmPRNTransaction in Own Shares
21st Nov 20257:56 amRNSNet Asset Value(s)
20th Nov 20255:13 pmPRNTransaction in Own Shares
20th Nov 20254:26 pmPRNHolding(s) in Company
20th Nov 20257:45 amRNSNet Asset Value(s)
19th Nov 20255:21 pmPRNTransaction in Own Shares
19th Nov 202511:12 amPRNNon-Executive Director Declaration
19th Nov 20257:48 amRNSNet Asset Value(s)
18th Nov 20255:29 pmPRNTransaction in Own Shares
18th Nov 20257:45 amRNSNet Asset Value(s)
17th Nov 20255:40 pmPRNTransaction in Own Shares
17th Nov 20257:57 amRNSNet Asset Value(s)
14th Nov 20255:42 pmPRNTransaction in Own Shares
14th Nov 20253:54 pmPRNHolding(s) in Company
14th Nov 202511:01 amPRNFinal Dividend Exchange Rate
14th Nov 20257:57 amRNSNet Asset Value(s)
13th Nov 20255:05 pmPRNTransaction in Own Shares
13th Nov 20258:02 amRNSNet Asset Value(s)
12th Nov 20255:20 pmPRNTransaction in Own Shares
12th Nov 202512:48 pmPRNTransaction in Own Shares
12th Nov 20257:36 amRNSNet Asset Value(s)
11th Nov 20257:40 amRNSNet Asset Value(s)
11th Nov 20257:00 amRNS-RKepler Trust Intelligence: New Research
10th Nov 20257:31 amRNSNet Asset Value(s)
7th Nov 20257:53 amRNSNet Asset Value(s)
6th Nov 20257:56 amRNSNet Asset Value(s)
5th Nov 20252:18 pmPRNCancellation of Treasury Shares
5th Nov 20257:42 amRNSNet Asset Value(s)
4th Nov 20257:31 amRNSNet Asset Value(s)
3rd Nov 20254:04 pmPRNTotal Voting Rights
3rd Nov 20257:50 amRNSNet Asset Value(s)
31st Oct 20258:00 amRNSNet Asset Value(s)
30th Oct 20257:46 amRNSNet Asset Value(s)
29th Oct 202510:15 amPRNRepurchase Timetable
29th Oct 20257:39 amRNSNet Asset Value(s)
28th Oct 20257:32 amRNSNet Asset Value(s)
27th Oct 20257:56 amRNSNet Asset Value(s)
24th Oct 202512:29 pmPRNResult of Extraordinary General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.